By Katherine Seley-Radtke, professor, Chemistry and Biochemistry, UMBC With the FDA approving Gilead’s Remdesivir as an emergency use treatment for the most acute cases of COVID-19, many...
May 6, 2020
·
2:19 PM
myUMBC is a UMBC limited public community forum for information sharing and dialogue. As a public institution, UMBC generally may not limit a community member's right to free speech on this forum. UMBC does not endorse the views expressed or information presented here, unless specifically stated in an official UMBC post. Learn more...